From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
SEEK B is a quality improvement program designed to support clinicians integrate hepatitis B screening and management. The program consists of three online learning that guides participants through hepatitis B clinical and auditing, from data cleaning through to linking patients in ongoing care. Completing SEEK B aims to increase the number of people identified for […]
This interactive 90-minute training provides medical and nurse practitioners who prescribe HBV antiviral medications an opportunity to apply their knowledge and skills to practical case studies. Case scenarios are developed by ASHM clinical advisors or local experts to meet the identified learning needs of medical practitioners, which vary from each State and Territory. Attendees are […]
Upon successful completion of this free training and the associated case assessment, participants will increase their confidence in managing and prescribing section 100 (s100) drugs for the management of hepatitis B in Australia and be eligible to display on ASHM’s HBV Prescriber Map. Date, Time, and Platform: Speakers: Learning Outcomes: On completion of this course […]
Upon successful completion of this free training and the associated case assessment, participants will increase their confidence in managing and prescribing section 100 (s100) drugs for the management of hepatitis B in Australia and be eligible to display on ASHM’s HBV Prescriber Map. Date, Time, and Platform: Speakers: Learning Outcomes: On completion of this course […]
Join us for a 90 minute networking event focused on strengthening hepatitis B care across primary and specialist settings. As we re-launch of the B-Referred project, we will showcase new resources designed to support clinicians in navigating referral pathways, assessing the suitability of primary care management, discussing care options with patients, and facilitating communication between […]
As of 1 September 2026, Australian clinicians no longer need specialist accreditation to prescribe hepatitis B antiviral treatments for initiation and maintenance therapy. In addition, authorised nurse practitioners can now prescribe hepatitis C medicine under the s100 program. This important reform follows sustained advocacy from ASHM, Hepatitis Australia and sector partners to improve timely and […]
This interactive 90-minute training provides medical and nurse practitioners who prescribe HBV antiviral medications an opportunity to apply their knowledge and skills to practical case studies. Case scenarios are developed by ASHM clinical advisors or local experts to meet the identified learning needs of medical practitioners, which vary from each State and Territory. Attendees are […]
This workshop provides primary care clinicians with the knowledge, practical skills and resources to strengthen STI screening, diagnosis and management, with a focus on priority populations. It also explores strategies for preventing HIV transmission, including the role of HIV prevention and testing, and highlights the importance of timely contact tracing and partner notification in supporting […]
From 14-17 August 2026, five healthcare professionals selected for the HBV s100 Prescriber Scholarship attended the 16th Australasian Viral Hepatitis Conference (VH2026) in Walyalup (Fremantle). Over three days, scholarship recipients learnt about the latest developments and work happening across the region in viral hepatitis care, and connected with leading experts and fellow healthcare professionals at networking events, including the official Scholarship Meetup. Read the below reflections from these scholarship recipients as they explore their experiences […]
From 12-14 August 2026, the 16th Australasian Viral Hepatitis Conference (VH2026) took place in Walyalup (Fremantle), on the traditional lands of the Whadjuk Noongar people. The conference brought together people living with hepatitis, peers, nurses, GPs, specialists, researchers and decision-makers to share practical, evidence-informed solutions that strengthen prevention, testing, treatment and long-term care in every setting. Cherie Bennett, Nursing Policy and Advocacy Lead at ASHM, reflects on the […]
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2026 ASHM